Holen Sie sich die Stockscreener-App
11.21
4.60%
-0.54
Handel nachbörslich:
11.15
-0.06
-0.54%
Phathom Pharmaceuticals Inc Aktie (PHAT) Neueste Nachrichten
Phathom Pharmaceuticals (NASDAQ:PHAT) Trading Down 4.1%Time to Sell? - MarketBeat
MACD Signal: How does C F Financial Corporation correlate with NasdaqIPO Watch & AI Based Trade Execution Alerts - khodrobank.com
Will Phathom Pharmaceuticals Inc. stock recover after recent drop2025 Big Picture & Safe Entry Zone Identification - newser.com
Phathom Pharmaceuticals (PHAT) Upgraded to Buy: Here's Why - Yahoo Finance
Dip Buying: What is Phathom Pharmaceuticals Incs book value per shareJuly 2025 Gainers & Entry Point Confirmation Alerts - khodrobank.com
Meme Stocks: Does Phathom Pharmaceuticals Inc. stock have upside surprise potentialEarnings Overview Summary & Community Verified Trade Alerts - khodrobank.com
Real time alert setup for Phathom Pharmaceuticals Inc. performanceEarnings Recap Summary & High Conviction Buy Zone Alerts - newser.com
Bull Bear: Can Phathom Pharmaceuticals Inc. weather a recessionTrade Volume Summary & Technical Entry and Exit Alerts - khodrobank.com
Woodline Partners LP Has $4.71 Million Stock Holdings in Phathom Pharmaceuticals, Inc. $PHAT - MarketBeat
Investor Mood: Is Phathom Pharmaceuticals Inc backed by strong institutional buyingDay Trade & Fast Entry and Exit Trade Plans - khodrobank.com
Quarterly Trades: Is Phathom Pharmaceuticals Inc backed by strong institutional buyingJuly 2025 Volume & Fast Entry High Yield Tips - khodrobank.com
Jobs Data: What hedge funds are buying Phathom Pharmaceuticals Inc2025 Historical Comparison & Precise Entry and Exit Recommendations - khodrobank.com
Recap Report: How correlated is Phathom Pharmaceuticals Inc to the S P5002025 Market Outlook & Accurate Entry and Exit Point Alerts - khodrobank.com
Phathom Pharmaceuticals (NASDAQ:PHAT investor five-year losses grow to 69% as the stock sheds US$66m this past week - simplywall.st
Pullback Watch: Is Phathom Pharmaceuticals Inc a strong growth stockJuly 2025 Highlights & Free Reliable Trade Execution Plans - خودرو بانک
Jacobs Levy Equity Management Inc. Invests $3.74 Million in Phathom Pharmaceuticals, Inc. $PHAT - MarketBeat
Fund Flows: Is Phathom Pharmaceuticals Inc. backed by strong institutional buyingJuly 2025 Levels & Fast Moving Trade Plans - khodrobank.com
Profit Review: Is Phathom Pharmaceuticals Inc forming a breakout patternProduct Launch & Daily Risk Controlled Trade Plans - khodrobank.com
Craig-Hallum Maintains Phathom Pharmaceuticals(PHAT.US) With Buy Rating - 富途牛牛
Phathom says FDA confirmed Voqueza exclusivity through May 2032 - MSN
Phathom Pharmaceuticals officer sells $5573 in stock By Investing.com - Investing.com Canada
Phathom Pharmaceuticals officer sells $5573 in stock - Investing.com
101,520 Shares in Phathom Pharmaceuticals, Inc. $PHAT Purchased by Nuveen LLC - MarketBeat
Wall Street Analysts See a 66.13% Upside in Phathom Pharmaceuticals (PHAT): Can the Stock Really Move This High? - Yahoo Finance
Recovery Signals Appearing in Phathom Pharmaceuticals Inc. Charts2025 EndofYear Setup & Weekly High Return Stock Opportunities - beatles.ru
Phathom Pharmaceuticals: The IP Question Is Answered, But Can Management Deliver (Rating Upgrade) - Seeking Alpha
Chart based analysis of Phathom Pharmaceuticals Inc. trendsOil Prices & Capital Protection Trade Alerts - Newser
Is Phathom Pharmaceuticals Inc. stock overvalued or fairly pricedGDP Growth & Expert Verified Stock Movement Alerts - خودرو بانک
Russell Investments Group Ltd. Invests $262,000 in Phathom Pharmaceuticals, Inc. $PHAT - MarketBeat
Aug Breakouts: Can Phathom Pharmaceuticals Inc. weather a recession2025 Technical Overview & Community Verified Watchlist Alerts - خودرو بانک
Signal strength of Phathom Pharmaceuticals Inc. stock in tech scanners2025 Technical Overview & Stepwise Trade Execution Plans - Newser
Visual analytics tools that track Phathom Pharmaceuticals Inc. performanceCEO Change & Consistent Growth Equity Picks - Newser
What the charts say about Phathom Pharmaceuticals Inc. todayWeekly Risk Summary & AI Enhanced Trading Signals - Newser
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
What recovery options are there for Phathom Pharmaceuticals Inc.2025 Volatility Report & Free Technical Confirmation Trade Alerts - Newser
How to forecast Phathom Pharmaceuticals Inc. trends using time series2025 Big Picture & Capital Efficiency Focused Ideas - Newser
Institutional scanner results for Phathom Pharmaceuticals Inc.Earnings Performance Report & AI Driven Stock Movement Reports - Newser
Is Phathom Pharmaceuticals Inc. building a consolidation base2025 Price Momentum & Weekly Hot Stock Watchlists - Newser
Has Phathom Pharmaceuticals Inc. formed a bullish divergenceMarket Performance Summary & Capital Protection Trade Alerts - Newser
How hedge fund analytics apply to Phathom Pharmaceuticals Inc. stock2025 Key Lessons & Daily Volume Surge Trade Alerts - Newser
Detecting support and resistance levels for Phathom Pharmaceuticals Inc.Trade Volume Summary & Growth Focused Entry Point Reports - Newser
What’s next for Phathom Pharmaceuticals Inc. stock priceWeekly Investment Recap & AI Based Buy and Sell Signals - Newser
Will Phathom Pharmaceuticals Inc. stock recover after earningsStock Surge & Accurate Intraday Trading Signals - خودرو بانک
Is Phathom Pharmaceuticals Inc. a turnaround storyWeekly Trade Analysis & Verified Short-Term Trading Plans - خودرو بانک
Is Phathom Pharmaceuticals Inc. backed by strong institutional buyingJuly 2025 Drop Watch & Risk Managed Investment Signals - خودرو بانک
Momentum divergence signals in Phathom Pharmaceuticals Inc. chartWeekly Profit Recap & Precise Swing Trade Entry Alerts - Newser
Dividend Watch: Is Phathom Pharmaceuticals Inc. a top pick in the sector2025 Risk Factors & Verified Short-Term Trading Plans - خودرو بانک
Advanced analytics toolkit walkthrough for Phathom Pharmaceuticals Inc.Earnings Summary Report & Daily Momentum Trading Reports - Newser
Is Phathom Pharmaceuticals Inc. still worth holding after the dipWeekly Trade Report & Community Verified Trade Alerts - Newser
How to read the order book for Phathom Pharmaceuticals Inc.Portfolio Risk Summary & Fast Moving Trade Plans - Newser
1.43%
0.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):